Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) (NCT01697579)Merck Sharp & Dohme LLC2012-12-13
Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers (NCT01779024)National Institute on Alcohol Abuse and Alcoholism (NIAAA)2012-12-13
Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy (NCT03838666)Bioinova, s.r.o.2012-12-12
Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis (NCT01746420)BioMimetic Therapeutics2012-12-12
A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012) (NCT01709318)Organon and Co2012-12-12
Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) (NCT01594281)Novartis Pharmaceuticals2012-12-11
Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer (NCT01670877)Washington University School of Medicine2012-12-11
Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR) (NCT01573702)UNC Lineberger Comprehensive Cancer Center2012-12-11
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes (NCT01690520)Nohla Therapeutics, Inc.2012-12-11
Comparative Assessment of Intra-articular Knee Injections of Platelet-rich Plasma (PRP) and Hyaluronic Acid in the Treatment of Knee Osteoarthritis (NCT01697423)Assistance Publique Hopitaux De Marseille2012-12-11
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders (NCT01720316)Mclean Hospital2012-12-10
Reolysin in Previously Treated Advanced/Metastatic, Non Small Cell Lung Cancer Receiving Standard Salvage Therapy (NCT01708993)Canadian Cancer Trials Group2012-12-10
Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations (NCT01752920)Basilea Pharmaceutica2012-12-10
Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme (NCT01591577)Jonsson Comprehensive Cancer Center2012-12-07
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab (NCT01723826)Genentech, Inc.2012-12-07
A Study of Different Doses of Grazoprevir (MK-5172) Given With Pegylated Interferon Alfa-2b and Ribavirin to Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-038) (NCT01710501)Merck Sharp & Dohme LLC2012-12-07
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer (NCT01750073)University of Nebraska2012-12-07
A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine (NCT02692170)Aribio Lab Co., Ltd.2012-12-07
Bortezomib Based Consolidation in Multiple Myeloma Patients Completing Stem Cell Transplant (NCT01706666)Mayo Clinic2012-12-07
Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents (NCT01721109)Gilead Sciences2012-12-06
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis (NCT02467608)Orient Pharma Co., Ltd.2012-12-06
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer (NCT01622868)National Cancer Institute (NCI)2012-12-06
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant (NCT01640301)Fred Hutchinson Cancer Center2012-12-06
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia (NCT01743859)University of Colorado, Denver2012-12-06
Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) (NCT01672866)Gilead Sciences2012-12-05
Phase 2a EBA Trial of AZD5847 (NCT01516203)National Institute of Allergy and Infectious Diseases (NIAID)2012-12-05
Preventing Sexual Dysfunction With Aromatase Inhibitors (NCT01603303)M.D. Anderson Cancer Center2012-12-05
Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma (NCT01693068)EMD Serono2012-12-05
Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease (NCT01696396)Amgen2012-12-04
Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain (NCT01709214)Tris Pharma, Inc.2012-12-04
Biomarker Directed Treatment in Metastatic Colorectal Cancer (NCT01703390)Arbeitsgemeinschaft medikamentoese Tumortherapie2012-12-04
A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain (NCT01767090)Astellas Pharma Europe B.V.2012-12-04
Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma (NCT01718743)M.D. Anderson Cancer Center2012-12-03
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) (NCT01702558)Hoffmann-La Roche2012-12-03
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer (NCT01693783)National Cancer Institute (NCI)2012-12-03
A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab (NCT01743950)University of Wisconsin, Madison2012-12-03
Baclofen for Treating Anxiety and Alcoholism (NCT01751386)National Institute on Alcohol Abuse and Alcoholism (NIAAA)2012-12-03
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Previously Treated Advanced Non-small Cell Lung Cancer (NCT01620190)University of Washington2012-12-02
Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose) (NCT01743768)Sterna Biologicals GmbH & Co. KG2012-12-01
Intravenous Bicarbonate To Verify The Correct Position of IV Catheters in Oncological Patients Oncological Patients Receiving Chemotherapy (NCT01748097)Sheba Medical Center2012-12-01
A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer (NCT01801904)National Cancer Institute, Naples2012-12-01
A Phase Ib Study of Fruquintinib in 3rd Line mCRC (NCT01975077)Hutchison Medipharma Limited2012-12-01
The Effects of Hydrogen-rich Formulation for Treatment of Sport-related Soft Tissue Injuries (NCT01759498)Center for Health Sciences, Serbia2012-12-01
Bone Marrow Derived Stem Cell Transplantation in T2DM (NCT01759823)Post Graduate Institute of Medical Education and Research, Chandigarh2012-12-01
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (NCT01723696)Oregon Health and Science University2012-12-01
Vinorelbine-ifosfamide Versus Gefitinib for EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients (NCT01749072)Peking Union Medical College Hospital2012-12-01
Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH (NCT01735617)Neurocrine UK Limited2012-12-01
Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation (NCT01660633)Acrotech Biopharma Inc.2012-12-01
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. (NCT04623242)Washington University School of Medicine2012-12-01
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors (NCT01525082)Shaheen Shagufta2012-12-01
Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease (NCT01463215)Exsar Corporation2012-12-01
Smoking, Sex Hormones, and Pregnancy (NCT01811225)University of Minnesota2012-12-01
Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery (NCT01730339)Pfizer2012-12-01
Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation (NCT02148016)Sun Yat-sen University2012-12-01
A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin (NCT01729403)Hoffmann-La Roche2012-12-01
Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT01777646)Brainstorm-Cell Therapeutics2012-12-01
A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer (NCT01703091)Eli Lilly and Company2012-12-01
Safety and Tolerability of I-040302 in Children and Young Adults With Solitary Bone Cysts (NCT00459641)Kuros Biosurgery AG2012-12-01
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents (NCT01731119)University of North Carolina, Chapel Hill2012-12-01
Is Analgesic Effect of Low Dose Ketamine-midazolam the Same as Morphine (NCT01807429)Isfahan University of Medical Sciences2012-12-01
WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8 (NCT01659437)University Medical Center Groningen2012-12-01
AGN-199201 for the Treatment of Erythema With Rosacea (NCT01735201)Allergan2012-12-01
Improving the Treatment for Women With Early Stage Cancer of the Uterus (NCT01686126)Queensland Centre for Gynaecological Cancer2012-12-01
Ciprofloxacin BioThrax Co-Administration Study (NCT01753115)Emergent BioSolutions2012-12-01
Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection (NCT01094132)British Columbia Cancer Agency2012-12-01
A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen (NCT01714414)Michael Hoelscher2012-12-01
Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal (NCT01843452)Centre Hospitalier Universitaire Vaudois2012-12-01
7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease (NCT01704404)Mylan Inc.2012-12-01
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma (NCT01716754)Novartis Pharmaceuticals2012-12-01
Molecularly Tailored Therapy for Pancreas Cancer (NCT01888978)Georgetown University2012-12-01
Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders (NCT01922999)Southeast Renal Research Institute2012-12-01
OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone (NCT01681433)Costantine Albany2012-12-01
Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer (NCT01757366)Hebei Tumor Hospital2012-12-01
Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 1 of 4) (NCT01758432)Portola Pharmaceuticals2012-12-01
Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under One (NCT01546935)University of Oxford2012-12-01
The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B (NCT02965859)Guangzhou Yipinhong Pharmaceutical CO.,LTD2012-12-01
Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease (NCT01696474)Gruppo Italiano Malattie EMatologiche dell'Adulto2012-12-01
CNDO-109-AANK for AML in First Complete Remission (CR1) (NCT01520558)Coronado Biosciences, Inc.2012-12-01
A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus (NCT01792635)Pfizer2012-12-01
XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach (NCT01798251)Harbin Medical University2012-12-01
NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia (NCT01733121)Neurocrine Biosciences2012-12-01
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer (NCT01698281)AEterna Zentaris2012-12-01
Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART). (NCT02054286)Theravectys S.A.2012-12-01
Pharmacokinetic Study of Deferiprone in Paediatric Patients (NCT01740713)Consorzio per Valutazioni Biologiche e Farmacologiche2012-12-01
A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management (NCT02468128)Lumosa Therapeutics Co., Ltd.2012-12-01
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer (NCT01729884)University of Washington2012-12-01
JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis (NCT01795677)French Innovative Leukemia Organisation2012-12-01
Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma (NCT01755975)Memorial Sloan Kettering Cancer Center2012-12-01
Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain (NCT03749408)Cairo University2012-12-01
Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis (NCT01879202)Medical University of Vienna2012-12-01
Trismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients (NCT01733797)Brynn Chappell2012-12-01
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia (NCT01670084)Mayo Clinic2012-12-01
Pharmacokinetic Study of CXB909 in Healthy Male Subjects (NCT01505907)CeNeRx BioPharma Inc.2012-12-01
Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4) (NCT03578146)Portola Pharmaceuticals2012-12-01
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 (NCT01760005)Washington University School of Medicine2012-12-01
Efficacy and Safety of Topical Essential Oil Extracted From Zingiber Cassumunar Rokb in Osteoarthritis (NCT01794260)Mahidol University2012-12-01
A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy (NCT01712061)Pfizer2012-12-01
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01503229)University of Washington2012-12-01
Clinical Trial to Evaluate Bone Marrow Stem Cell Therapy for PSP, a Rare Form of Parkinsonism (NCT01824121)Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2012-12-01
A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors (NCT01764087)Hanmi Pharmaceutical Company Limited2012-12-01
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.